FHA
HAE icon

Flagship Harbor Advisors’s Haemonetics HAE Stock Holding History

Flagship Harbor Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25
Closed -$2K – 1015
2020
Q3 		$2K Sell
25
-100
-80% -$8.74K ﹤0.01% 1721
2020
Q2 		$11K Hold
125
– – ﹤0.01% 1322
2020
Q1 		$12K Hold
125
– – ﹤0.01% 1168
2019
Q4 		$14K Buy
125
+100
+400% +$12.1K ﹤0.01% 1230
2019
Q3 		$3K Hold
25
– – ﹤0.01% 1599
2019
Q2 		$3K Hold
25
– – ﹤0.01% 1607
2019
Q1 		$2K Sell
25
-55
-69% -$5K ﹤0.01% 1669
2018
Q4 		$8K Hold
80
– – ﹤0.01% 1299
2018
Q3 		$9K Buy
80
+25
+45% +$2.59K ﹤0.01% 1471
2018
Q2 		$4K Buy
+55
New +$4.64K ﹤0.01% 1695

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Flagship Harbor Advisors's HAE Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Haemonetics (HAE) in Q4 2020, closing a stake of 25 shares — an estimated $2K sold.

Flagship Harbor Advisors first reported a position in HAE in Q2 2018 and held it in 10 quarters. The position peaked at $14K in Q4 2019. 286 funds tracked by Wall St. Rank hold HAE as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Haemonetics position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 25 Haemonetics shares in Q4 2020, an estimated $2K.
  • Flagship Harbor Advisors first reported a position in Haemonetics in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Haemonetics position peaked at $14K in Q4 2019.
  • 286 funds tracked by Wall St. Rank held Haemonetics as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.